Healthcare

Parliamentary panel bats for cap on private hospital room rents

The panel has recommended that basic hospital room tariffs should not exceed average room rates at three-star hotels in the peripheral area or vicinity of the facility

Parl panel suggests capping pvt hospital room rates at 3-star hotel tariff

A parliamentary panel has proposed a 3-star hotel rate benchmark for pvt hospital rooms in metros, citing wide cost gaps between public and private healthcare, calling for greater billing transparency

US vaccine policy risks undermining use of tech to advance medical science

Flaws in US vaccine policy could make it impossible to leverage technology in optimal ways to advance medical science

CGHS dues delayed by up to 18 months, strain private hospital finances

Providers say delayed payments, unexplained claim rejections and below-cost reimbursement for some cancer drugs are straining finances despite recently revised CGHS rates

KKR pumps ₹13,188 cr into India expansion, acquires Medicover hospitals

KKR will acquire Medicover India's hospital business in a €1.2 billion deal, strengthening its healthcare portfolio and expanding its footprint across southern and western India

Medicover to sell India hospital business to KKR for $1.39 billion

The Swedish healthcare provider will sell its India hospital operations to KKR-managed funds as it sharpens its focus on key European markets

Eli Lilly raises annual revenue expectation as GLP-1 drugs fuel growth

Eli Lilly raised its full-year revenue forecast after stronger-than-expected quarterly results, driven by robust demand for Mounjaro and Zepbound

Dr Lal Path jumps 8% to 52-week high on Q1 beat; up to 25% upside on cards

Dr Lal PathLabs' share price jumped 8 per cent to a fresh 52-week high of ₹1,893.65 on the BSE today. The company has posted a better-than-expected Q1 show, prompting analysts to raise target prices.

Oriflame to sell India manufacturing operations to Akums subsidiary

The Swedish beauty brand will retain its commercial operations in India while entering a long-term manufacturing and supply partnership with Akums

Clinicians embrace AI tools, but hospitals lag on training, governance

A global survey of nearly 2,800 clinicians finds AI is now part of everyday healthcare, but weak trust, limited training and poor governance threaten its wider adoption in clinical practice

Plazza secures $15 million to expand AI-powered medicine delivery

Accel, Elevation Capital and Nexus Venture Partners co-led the Series A round as Plazza expands its AI-powered pharmacy network and inventory intelligence platform

Covering 'missing middle' can fix India's insurance gap: Sangita Reddy

NATHEALTH president also pitches prevention-led insurance, PPPs and a national mission to scale medical value travel

India setting new benchmarks in medical research, says Rajnath Singh

Defence Minister Rajnath Singh on Monday asserted that India is setting new benchmarks in medical research and developing indigenous solutions to global health challenges through gene therapy and nuclear medicine. India's health system is also emerging as more self-reliant, he said addressing the 22nd convocation ceremony of the King George's Medical University, Lucknow. "Today, India's health system has emerged as more self-reliant, accessible, affordable, modern and people-centric as compared to earlier times. Today, India is developing indigenous solutions to global health challenges through gene therapy, nuclear medicine, and other modern technologies," Singh said. The Lok Sabha MP said the country's scientists have successfully demonstrated an indigenous gene therapy for the treatment of haemophilia, while scientists at an institute in Pune have developed a state-of-the-art nanomedicine for treating breast cancer. The 'Production Linked Incentive' scheme, he said, has given fr

Heal policy paves way for Rajasthan's rise as a medical tourism hub

Rajasthan's Heal Policy 2025 aims to position the state as a global medical tourism hub with quality healthcare, digital services and investment-friendly incentives

Fortis signs O&M agreement for 300-bed hospital, enters Odisha market

Hospital chain Fortis Healthcare has signed an O&M agreement with Dion Group to operate a 300-bed hospital in Cuttack, marking its entry into Odisha and expanding its eastern India presence

ESIC plans to build own medical education system with new university

ESIC plans a deemed health sciences university to unify its medical colleges, standardise education, boost research and strengthen governance across its expanding network

Apollo Cancer Centres launches Guardant Health's Shield MCD test in India

Apollo Cancer Centres has partnered with Zydus Lifesciences to introduce Guardant Health's Shield Multi-Cancer Detection blood test, becoming the first healthcare institution in India to offer it

Fortis Healthcare signs pact with Dion Group for 300-bed Odisha hospital

The agreement marks Fortis Healthcare's first major presence in Odisha

Bank of Baroda settles case out-of-court with NMC Health for $600 million

State-owned Bank of Baroda (BoB) on Thursday said it reached an out-of-court settlement with NMC Health PLC, NMC Healthcare Ltd, and NMC Holding Ltd, with USD 600 million (about Rs 5,700 crore) paid through its Abu Dhabi Branch. The case involved proceedings under Abu Dhabi Global Market (ADGM) and UK insolvency regulations, and the UAE civil law in relation to NMC Health PLC, NMC Holding Ltd and NMC Healthcare Ltd, BoB said in a regulatory filing. "NMC Health PLC, NMC Healthcare Ltd, NMC Holding Ltd, and their respective Joint Administrators, have resolved the claims between them and the Bank of Baroda in consideration for, inter alia, payment by Bank of Baroda of USD 600 million, pursuant to a settlement agreement," it said. All claims, causes of action, etc. between them have been resolved without admission of liability or wrongdoing, it said. The settlement agreement and its terms otherwise remain confidential, it said, adding that the liability of the bank in these proceedings

Zydus, Sunshine Healthcare form $20-million JV for Sri Lanka pharma plant

The joint venture will invest over $20 million in a pharmaceutical manufacturing facility in Sri Lanka to boost local drug production and reduce reliance on imports